Insiders who reported open-market trades in the last 12 months at the companies Jason O'Byrne files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
David C. Myles - $3.11M in OLMA purchases and sales in the last 12 months
Jason O'Byrne is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason O'Byrne submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason O'Byrne been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($69K) across all tracked filings.
Jason O'Byrne is CHIEF FINANCIAL OFFICER of Olema Pharmaceuticals, Inc. (OLMA). 6 SEC Form 4 filings on record going back to 2024, most recently on 2 September 2026. Most recent open-market trade: sold $16K of VIR on 26 February 2026. Lifetime open-market sales: $69K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Jason O'Byrne.
InsiderAlpha's records for Jason O'Byrne go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 5 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
